You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Maintenance setting

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Insomnia, Secondary, Sleep Disturbance, Sleep Trial in Encinitas (Dreem 3 System vs WatchPAT One, Usability Questionnaire)

Completed
  • Insomnia, Secondary
  • +3 more
  • Dreem 3 System vs WatchPAT One
  • Usability Questionnaire
  • Encinitas, California
    Dreem Health
Nov 24, 2022

First-line Olaparib Mono-maintenancerapy-a Multicenter,

Not yet recruiting
  • Ovarian Neoplasms
  • Olaparib mono-maintenance therapy
  • (no location specified)
Dec 8, 2021

Sleep Disturbance, Insomnia, Music Listening Intervention Trial in Montréal (Music listening intervention, Non-musical sounds

Recruiting
  • Sleep Disturbance
  • +3 more
  • Music listening intervention
  • Non-musical sounds listening intervention
  • Montréal, Quebec, Canada
    St. Mary's Hospital Center
May 25, 2022

Ovarian Cancer Trial in Hong Kong (Niraparib)

Recruiting
  • Ovarian Cancer
  • Hong Kong, Hong Kong
    The University of Hong Kong
Sep 27, 2021

Insomnia Trial in Newark, Rennes (Dreem 3 System vs PSG)

Completed
  • Insomnia
  • Dreem 3 System vs PSG
  • Newark, New Jersey
  • +1 more
Jul 28, 2022

Olaparib Real-world Utilization and Clinical Outcomes in France,

Active, not recruiting
  • Ovary Cancer
  • Saint Pierre, La Réunion (oversea France), France
  • +51 more
Jan 23, 2023

Opioid-Related Disorders, Substance-Related Disorders Trial in New Haven (Buprenorphine)

Completed
  • Opioid-Related Disorders
  • Substance-Related Disorders
  • New Haven, Connecticut
    APT Residential Services Division
Jul 3, 2020

Insomnia Trial in Bracknell (SilverCloud)

Completed
  • Insomnia
  • SilverCloud
  • Bracknell, United Kingdom
    Berkshire NHS Foundation Trust
Jan 28, 2021

Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Research Institute / UPMC Magee Womens Hospital
Jul 3, 2023

Carcinoma, Ovarian Epithelial Trial in San Fermo Della Battaglia, Padova (Olaparib, Bevacizumab)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • San Fermo Della Battaglia, Como, Italy
  • +1 more
Nov 2, 2023

Overweight and Obesity Trial in Providence (Training to Identify Eligible Patients and Direct them to Online Obesity Treatment

Unknown status
  • Overweight and Obesity
  • Training to Identify Eligible Patients and Direct them to Online Obesity Treatment Program
  • +5 more
  • Providence, Rhode Island
    Weight Control and Diabetes Resarch Center
Feb 18, 2020

Obinutuzumab in Combination With Lenalidomide in Relapsed or

Recruiting
  • Follicular Lymphoma
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital ,Chinese Aca
    Apr 27, 2023

    Acute Myeloid Leukemia (AML) in Remission Trial in Washington (CPX-351)

    Recruiting
    • Acute Myeloid Leukemia (AML) in Remission
    • Washington, District of Columbia
      Georgetown Lombardi Comprehensive Cancer Center
    May 3, 2022

    Metastatic Colorectal Cancer Trial (Anti-PD-1 Monoclonal Antibody + Capecitabine)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • Tislelizumab + Capecitabine
    • Best supportive care
    • (no location specified)
    Sep 22, 2022

    Safety of Niraparib in Korean Primary and Recurrent Epithelial

    Completed
    • Epithelial Ovarian Cancer
    • Seoul, Korea, Republic of
      Department of Obstetrics and Gynecology, University of Ulsan Col
    Oct 11, 2023

    MDD Trial in Providence (EMA Monitoring, Scheduling Maintenance TMS sessions)

    Recruiting
    • Major Depressive Disorder
    • EMA Monitoring
    • Scheduling Maintenance TMS sessions
    • Providence, Rhode Island
      Butler Hospital
    Nov 28, 2023

    3rd Line Therapy or More to Treat Adult CML- CP in Real World

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Oct 16, 2023

    Adjunctive Anti-seizure Medication Real World Evidence Study

    Recruiting
    • Epilepsy
    • ASM as adjunctive therapy
    • Milan, Italy
      Fondazione IRCCS Istituto Neurologico "Carlo Besta" U.O. Epilett
    May 17, 2023

    iTMS - Implementing Transcranial Magnetic Stimulation to Assess

    Recruiting
    • Stroke
      • Hammel, Aarhus, Denmark
        Hammel Neurorehabilitation Centre and University Research Clinic
      Nov 30, 2023

      Diffuse Large B Cell Lymphoma Trial in Philadelphia (Nivolumab, IV, 240 mg)

      Active, not recruiting
      • Diffuse Large B Cell Lymphoma
      • Nivolumab, IV, 240 mg
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      Jan 3, 2023

      Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

      Not yet recruiting
      • Myeloid Malignancy
      • Acute Myeloid Leukemia
      • Cleveland, Ohio
        University Hospitals Seidman Cancer, Case Comprehensive Cancer C
      Nov 8, 2023

      Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

      Recruiting
      • Neuroblastoma
      • +2 more
      • Columbus, Ohio
        Nationwide Children's Hospital
      Dec 20, 2022

      Obesity Trial in Minneapolis (drug, dietary supplement, other)

      Recruiting
      • Obesity
      • Minneapolis, Minnesota
        University of Minnesota
      Oct 28, 2022

      Multiple Myeloma Trial in Augusta (Lenalidomide, Vitamin D - Intensified, Vitamin D - Therapeutic)

      Not yet recruiting
      • Multiple Myeloma
      • Augusta, Georgia
        Georgia Cancer Center at Augusta University
      Apr 26, 2023

      Glioblastoma Trial in Berlin (Radiofrequency electromagnetic field treatment)

      Recruiting
      • Glioblastoma
      • Radiofrequency electromagnetic field treatment
      • Berlin, Germany
        Charité Universitätsmedizin Berlin
      Nov 15, 2023